Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer

We introduce a new proliferation marker, securin (pituitary tumour-transforming 1 (PTTG1)), analysed in invasive ductal breast carcinomas by cDNA microarrays and immunohistochemistry. In cDNA microarray of a total of 4000 probes of genes, securin was revealed with a significant change in expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Talvinen, K, Tuikkala, J, Nevalainen, O, Rantanen, A, Hirsimäki, P, Sundström, J, Kronqvist, P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480969/
https://www.ncbi.nlm.nih.gov/pubmed/18594525
http://dx.doi.org/10.1038/sj.bjc.6604475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480969/
https://www.ncbi.nlm.nih.gov/pubmed/18594525
http://dx.doi.org/10.1038/sj.bjc.6604475

Ejemplares similares